Literature DB >> 26573704

Clinical Management and Outcomes of Adrenal Hemorrhage Following Adrenal Vein Sampling in Primary Aldosteronism.

Silvia Monticone1, Fumitoshi Satoh1, Anna S Dietz1, Remi Goupil1, Katharina Lang1, Francesca Pizzolo1, Richard D Gordon1, Ryo Morimoto1, Martin Reincke1, Michael Stowasser1, Paolo Mulatero2.   

Abstract

Aldosterone-producing adenoma and bilateral adrenal hyperplasia account for >90% of all primary aldosteronism cases. Distinguishing between bilateral and unilateral disease is of fundamental importance because it allows targeted therapy. Adrenal vein sampling (AVS) is the only reliable means to preoperatively differentiate between unilateral and bilateral subtypes. A rare but serious complication of AVS is an adrenal hemorrhage (AH). We retrospectively examined in detail 24 cases of AH during AVS in 6 different referral hypertension centers. AH more often affected the right adrenal (n=18) than the left (n=5, P<0.001); 1 bilateral. Median duration of experience of the radiologist in AVS at the time of AH was 5.0 years (0.6-7.8) and AH occurred with both highly experienced (>10 years) and less experienced radiologists. Of 9 patients who suffered AH in the gland contralateral to an aldosterone-producing adenoma and who underwent complete (n=6) or partial (n=3) unilateral adrenalectomy, only one required long-term corticosteroid replacement for adrenal insufficiency. No reduction in blood pressure or biochemical resolution of primary aldosteronism occurred in any of those patients who experienced AH in the gland ipsilateral to an aldosterone-producing adenoma (n=6) or who had bilateral adrenal hyperplasia (n=9). No patient required invasive treatments to control bleeding or blood transfusion. In conclusion, AH usually has a positive outcome causing either no or minor effects on adrenal function, and AVS should remain the best approach to primary aldosteronism subtype differentiation.
© 2015 American Heart Association, Inc.

Entities:  

Keywords:  adrenal hemorrhage; adrenal vein sampling; aldosterone-producing adenoma; bilateral adrenal hyperplasia; primary aldosteronism

Mesh:

Year:  2015        PMID: 26573704     DOI: 10.1161/HYPERTENSIONAHA.115.06305

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  19 in total

Review 1.  Steroid Profiling and Immunohistochemistry for Subtyping and Outcome Prediction in Primary Aldosteronism-a Review.

Authors:  Finn Holler; Daniel A Heinrich; Christian Adolf; Benjamin Lechner; Martin Bidlingmaier; Graeme Eisenhofer; Tracy Ann Williams; Martin Reincke
Journal:  Curr Hypertens Rep       Date:  2019-09-03       Impact factor: 5.369

Review 2.  Hyperaldosteronism: How to Discriminate Among Different Disease Forms?

Authors:  Valentina Crudo; Silvia Monticone; Jacopo Burrello; Fabrizio Buffolo; Martina Tetti; Franco Veglio; Paolo Mulatero
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-05-02

3.  18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status.

Authors:  Yuta Tezuka; Yuto Yamazaki; Masaaki Kitada; Ryo Morimoto; Masataka Kudo; Kazumasa Seiji; Kei Takase; Yoshihide Kawasaki; Koji Mitsuzuka; Akihiro Ito; Jun Nishikawa; Noriko Asai; Yasuhiro Nakamura; Celso E Gomez-Sanchez; Sadayoshi Ito; Mari Dezawa; Hironobu Sasano; Fumitoshi Satoh
Journal:  Hypertension       Date:  2019-06       Impact factor: 10.190

Review 4.  Adrenal venous sampling in the diagnostic workup of primary aldosteronism.

Authors:  Matthias Johannes Betz; Christoph Johannes Zech
Journal:  Br J Radiol       Date:  2021-10-07       Impact factor: 3.039

5.  Adrenal venous sampling in primary aldosteronism: Experience of a Spanish multicentric study (Results from the SPAIN-ALDO Register).

Authors:  Marta Araujo-Castro; Miguel Paja Fano; Marga González Boillos; Begoña Pla Peris; Eider Pascual-Corrales; Ana María García Cano; Paola Parra Ramírez; Patricia Martín Rojas-Marcos; Jorge Gabriel Ruiz-Sanchez; Almudena Vicente Delgado; Emilia Gómez Hoyos; Rui Ferreira; Iñigo García Sanz; Mònica Recasens Sala; Rebeca Barahona San Millan; María José Picón César; Patricia Díaz Guardiola; Juan Jesús García González; Carolina M Perdomo; Laura Manjón Miguélez; Rogelio García Centeno; Juan Carlos Percovich; Ángel Rebollo Román; Paola Gracia Gimeno; Cristina Robles Lázaro; Manuel Morales-Ruiz; Felicia A Hanzu
Journal:  Endocrine       Date:  2022-06-25       Impact factor: 3.925

6.  Diagnosis of primary aldosteronism in the hypertension specialist centers in Italy: a national survey.

Authors:  Giacomo Pucci; Silvia Monticone; Claudia Agabiti Rosei; Giulia Balbi; Fabio Bertacchini; Fabio Ragazzo; Francesca Saladini; Martino F Pengo
Journal:  J Hum Hypertens       Date:  2018-08-06       Impact factor: 3.012

7.  Persistent Primary Aldosteronism Despite Iatrogenic Adrenal Hemorrhage After Adrenal Vein Sampling.

Authors:  Keisuke Okamura; Tetsu Okuda; Kazuyuki Shirai; Ichiro Abe; Kunihisa Kobayashi; Tatsu Ishii; Seiji Haraoka; Hidenori Urata
Journal:  J Clin Med Res       Date:  2017-12-01

Review 8.  Management of primary aldosteronism in patients with adrenal hemorrhage following adrenal vein sampling: A brief review with illustrative cases.

Authors:  Fady Hannah-Shmouni; Andrew Demidowich; Beatriz Rizkallah Alves; Gabriela Dockhorn Paluch; Dionysiou Margarita; Charalampos Lysikatos; Elena Belyavskaya; Richard Chang; Constantine A Stratakis
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-09-09       Impact factor: 3.738

9.  Approach to the Patient with Primary Aldosteronism: Utility and Limitations of Adrenal Vein Sampling.

Authors:  Adina F Turcu; Richard Auchus
Journal:  J Clin Endocrinol Metab       Date:  2021-03-25       Impact factor: 5.958

10.  Determination of adrenal hypersecretion in primary Aldosteronism without aldosterone-production adenomas.

Authors:  Fang Sun; Yangning Hong; Hexuan Zhang; Xiaoli Liu; Zhigang Zhao; Hongbo He; Zhencheng Yan; Zhiming Zhu
Journal:  BMC Endocr Disord       Date:  2021-05-31       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.